Skip to main content
Top
Published in: AIDS and Behavior 12/2016

01-12-2016 | Original Paper

Estimated Number of People Who Inject Drugs in San Francisco, 2005, 2009, and 2012

Authors: Yea-Hung Chen, Willi McFarland, Henry F. Raymond

Published in: AIDS and Behavior | Issue 12/2016

Login to get access

Abstract

Allocation of resources to public health responses depends on having plausible estimates of the size of the population at risk. Unfortunately, the numbers of people who inject drugs (PWID) are difficult to estimate since injection drug use is highly stigmatized. Though estimation methods exist, the robustness of the methods to their assumptions is not well understood. Comparisons between methods are also lacking; information regarding the successive-sampling method is particularly scarce. The present study used several methods—including the successive-sampling method—to produce population size estimates from three rounds of cross-sectional surveys of PWID in San Francisco. It compares these estimates across time and across method. Our summary estimates are 10,158 for 2005, 15,554 for 2009, and 22,500 for 2012. Though the point summaries suggest an increasing population, considerable uncertainty is involved. Comparisons between and within methods reveal high variability, suggesting dependence on assumptions and analytic choices. We conclude that further research is needed to improve upon the estimation methods or develop entirely new ones. Meanwhile, plausible estimates can be achieved via multiple methods while avoiding the pitfall of relying on a single method that may be highly biased and highly imprecise.
Literature
1.
go back to reference Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007;18(5):352–8.CrossRefPubMed Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007;18(5):352–8.CrossRefPubMed
2.
go back to reference Hagan H, Pouget ER, Des Jarlais DC, Lelutiu-Weinberger C. Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol. 2008;168(10):1099–109.CrossRefPubMedPubMedCentral Hagan H, Pouget ER, Des Jarlais DC, Lelutiu-Weinberger C. Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol. 2008;168(10):1099–109.CrossRefPubMedPubMedCentral
4.
go back to reference Wejnert C, Pham H, Oster AM, et al. HIV infection and HIV-associated behaviors among injecting drug users—20 cities, United States, 2009. MMWR Morb Mortal Wkly Rep. 2012;61(8):133–8. Wejnert C, Pham H, Oster AM, et al. HIV infection and HIV-associated behaviors among injecting drug users—20 cities, United States, 2009. MMWR Morb Mortal Wkly Rep. 2012;61(8):133–8.
5.
go back to reference Deiss RG, Rodwell TC, Garfein RS. Tuberculosis and illicit drug use: review and update. Clin Infect Dis. 2009;48(1):72–82.CrossRefPubMed Deiss RG, Rodwell TC, Garfein RS. Tuberculosis and illicit drug use: review and update. Clin Infect Dis. 2009;48(1):72–82.CrossRefPubMed
6.
go back to reference Perdue T, Hagan H, Thiede H, Valleroy L. Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men. AIDS Educ Prev. 2003;15(1):81–92.CrossRefPubMed Perdue T, Hagan H, Thiede H, Valleroy L. Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men. AIDS Educ Prev. 2003;15(1):81–92.CrossRefPubMed
7.
go back to reference Jones DL, Waldrop-Valverde D, Gonzalez P, et al. Mental health in HIV seronegative and seropositive IDUs in South Florida. AIDS Care. 2010;22(2):152–8.CrossRefPubMed Jones DL, Waldrop-Valverde D, Gonzalez P, et al. Mental health in HIV seronegative and seropositive IDUs in South Florida. AIDS Care. 2010;22(2):152–8.CrossRefPubMed
8.
go back to reference Mackesy-Amiti ME, Donenberg GR, Ouellet LJ. Prevalence of psychiatric disorders among young injection drug users. Drug Alcohol Depend. 2012;124(1–2):70–8.CrossRefPubMedPubMedCentral Mackesy-Amiti ME, Donenberg GR, Ouellet LJ. Prevalence of psychiatric disorders among young injection drug users. Drug Alcohol Depend. 2012;124(1–2):70–8.CrossRefPubMedPubMedCentral
9.
go back to reference Solet D, Hagan H, Nakagawara J, Plough A, Ball JK. Unintentional opiate overdose deaths–King County, Washington, 1990–1999. MMWR Morb Mortal Wkly Rep. 2000;49(28):636–40. Solet D, Hagan H, Nakagawara J, Plough A, Ball JK. Unintentional opiate overdose deaths–King County, Washington, 1990–1999. MMWR Morb Mortal Wkly Rep. 2000;49(28):636–40.
10.
go back to reference Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am J Public Health. 2001;91(11):1842–6.CrossRefPubMedPubMedCentral Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am J Public Health. 2001;91(11):1842–6.CrossRefPubMedPubMedCentral
11.
go back to reference Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend. 2005;80(3):297–302.CrossRefPubMed Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend. 2005;80(3):297–302.CrossRefPubMed
12.
go back to reference Backmund M, Schuetz C, Meyer K, Edlin BR, Reimer J. The risk of emergency room treatment due to overdose in injection drug users. J Addict Dis. 2009;28(1):68–73.CrossRefPubMed Backmund M, Schuetz C, Meyer K, Edlin BR, Reimer J. The risk of emergency room treatment due to overdose in injection drug users. J Addict Dis. 2009;28(1):68–73.CrossRefPubMed
13.
go back to reference Vlahov D, Wang C, Ompad D, et al. Mortality risk among recent-onset injection drug users in five US cities. Subst Use Misuse. 2008;43(3–4):413–28.CrossRefPubMed Vlahov D, Wang C, Ompad D, et al. Mortality risk among recent-onset injection drug users in five US cities. Subst Use Misuse. 2008;43(3–4):413–28.CrossRefPubMed
14.
go back to reference Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol. 2012;175(4):302–8.CrossRefPubMedPubMedCentral Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol. 2012;175(4):302–8.CrossRefPubMedPubMedCentral
15.
go back to reference UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. Guidelines on Estimating the Size of Populations Most at Risk to HIV. Geneva, Switzerland: World Health Organization; 2010. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. Guidelines on Estimating the Size of Populations Most at Risk to HIV. Geneva, Switzerland: World Health Organization; 2010.
16.
go back to reference Johnston LG, Prybylski D, Raymond HF, Mirzazadeh A, Manopaiboon C, McFarland W. Incorporating the service multiplier method in respondent-driven sampling surveys to estimate the size of hidden and hard-to-reach populations: case studies from around the world. Sex Transm Dis. 2013;40(4):304–10.CrossRefPubMed Johnston LG, Prybylski D, Raymond HF, Mirzazadeh A, Manopaiboon C, McFarland W. Incorporating the service multiplier method in respondent-driven sampling surveys to estimate the size of hidden and hard-to-reach populations: case studies from around the world. Sex Transm Dis. 2013;40(4):304–10.CrossRefPubMed
17.
go back to reference Shaghaghi A, Bhopal RS, Sheikh A. Approaches to recruiting ‘hard-to-reach’ populations into research: a review of the literature. Health Promot Perspect. 2011;1(2):86–94.PubMedPubMedCentral Shaghaghi A, Bhopal RS, Sheikh A. Approaches to recruiting ‘hard-to-reach’ populations into research: a review of the literature. Health Promot Perspect. 2011;1(2):86–94.PubMedPubMedCentral
18.
go back to reference Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999–2010. Vital Health Stat. 2013;1 (56). Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999–2010. Vital Health Stat. 2013;1 (56).
19.
go back to reference Substance Abuse and Mental Health Services Administration. Results from the 2010 national survey on drug use and health: summary of national findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011. Substance Abuse and Mental Health Services Administration. Results from the 2010 national survey on drug use and health: summary of national findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011.
20.
go back to reference MacKellar D, Valleroy L, Karon J, Lemp G, Janssen R. The young men’s survey: methods for estimating HIV seroprevalence and risk factors among young men who have sex with men. Public Health Rep. 1996;111(Suppl 1):138–44.PubMedPubMedCentral MacKellar D, Valleroy L, Karon J, Lemp G, Janssen R. The young men’s survey: methods for estimating HIV seroprevalence and risk factors among young men who have sex with men. Public Health Rep. 1996;111(Suppl 1):138–44.PubMedPubMedCentral
21.
go back to reference Johnston LG, Sabin K, Mai TH, Pham TH. Assessment of respondent driven sampling for recruiting female sex workers in two Vietnamese cities: reaching the unseen sex worker. J Urban Health. 2006;83(6 Suppl):i16–28.CrossRefPubMed Johnston LG, Sabin K, Mai TH, Pham TH. Assessment of respondent driven sampling for recruiting female sex workers in two Vietnamese cities: reaching the unseen sex worker. J Urban Health. 2006;83(6 Suppl):i16–28.CrossRefPubMed
22.
go back to reference Bernard HR, Killworth P, Johnsen EC, Shelley GA, McCarty C. Estimating the ripple effect of a disaster. Connections. 2001;24(2):18–22. Bernard HR, Killworth P, Johnsen EC, Shelley GA, McCarty C. Estimating the ripple effect of a disaster. Connections. 2001;24(2):18–22.
23.
go back to reference Bernard HR, Hallett T, Iovita A, et al. Counting hard-to-count populations: the network scale-up method for public health. Sex Transm Infect. 2010;86 (Suppl 2):ii11–ii15. Bernard HR, Hallett T, Iovita A, et al. Counting hard-to-count populations: the network scale-up method for public health. Sex Transm Infect. 2010;86 (Suppl 2):ii11–ii15.
24.
go back to reference Andrewartha HG. Introduction to the study of animal populations. 2nd ed. London: Chapman & Hall; 1970.CrossRef Andrewartha HG. Introduction to the study of animal populations. 2nd ed. London: Chapman & Hall; 1970.CrossRef
25.
go back to reference Seber GAF. The effects of trap response on tag recapture estimates. Biometrics. 1970;26(1):13–22.CrossRef Seber GAF. The effects of trap response on tag recapture estimates. Biometrics. 1970;26(1):13–22.CrossRef
26.
go back to reference Seber GAF. The estimation of animal abundance and related parameters. 2nd ed. London: C Griffin & Co; 1982. Seber GAF. The estimation of animal abundance and related parameters. 2nd ed. London: C Griffin & Co; 1982.
27.
go back to reference Hook EB, Regal RR. The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies. Am J Epidemiol. 1992;135(9):1060–7.PubMed Hook EB, Regal RR. The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies. Am J Epidemiol. 1992;135(9):1060–7.PubMed
28.
go back to reference Greenwood JA. Estimating number of narcotic addicts. Washington, DC: US Department of Justice; 1971.CrossRef Greenwood JA. Estimating number of narcotic addicts. Washington, DC: US Department of Justice; 1971.CrossRef
29.
go back to reference Surowiecki J. The wisdom of crowds: why the many are smarter than the few and how collective wisdom shapes business, economies, societies, and nations. New York: Doubleday Books; 2004. Surowiecki J. The wisdom of crowds: why the many are smarter than the few and how collective wisdom shapes business, economies, societies, and nations. New York: Doubleday Books; 2004.
30.
go back to reference Bickel PJ, Nair VN, Wang PC. Nonparametric inference under biased sampling from a finite population. Ann Stat. 1992;80:853–78.CrossRef Bickel PJ, Nair VN, Wang PC. Nonparametric inference under biased sampling from a finite population. Ann Stat. 1992;80:853–78.CrossRef
31.
go back to reference Handcock MS, Gile KJ, Mar CM. Estimating hidden population size using respondent-driven sampling data. Electronic Journal of Statistics. 2014;8(1):1491–521.CrossRefPubMedPubMedCentral Handcock MS, Gile KJ, Mar CM. Estimating hidden population size using respondent-driven sampling data. Electronic Journal of Statistics. 2014;8(1):1491–521.CrossRefPubMedPubMedCentral
32.
go back to reference Handcock MS, Gile KJ, Mar CM. Estimating the size of populations at high risk for HIV using respondent-driven sampling data. Biometrics. 2015. Handcock MS, Gile KJ, Mar CM. Estimating the size of populations at high risk for HIV using respondent-driven sampling data. Biometrics. 2015.
33.
go back to reference Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRef Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRef
34.
go back to reference Salganik MJ, Fazito D, Bertoni N, Abdo AH, Mello MB, Bastos FI. Assessing network scale-up estimates for groups most at risk of HIV/AIDS: evidence from a multiple-method study of heavy drug users in Curitiba. Brazil. Am J Epidemiol. 2011;174(10):1190–6.CrossRefPubMed Salganik MJ, Fazito D, Bertoni N, Abdo AH, Mello MB, Bastos FI. Assessing network scale-up estimates for groups most at risk of HIV/AIDS: evidence from a multiple-method study of heavy drug users in Curitiba. Brazil. Am J Epidemiol. 2011;174(10):1190–6.CrossRefPubMed
35.
36.
go back to reference Gallagher KM, Sullivan PS, Lansky A, Onorato IM. Behavioral surveillance among people at risk for HIV infection in the US: the National HIV Behavioral Surveillance System. Public Health Rep. 2007;122(Suppl 1):32–8.PubMedPubMedCentral Gallagher KM, Sullivan PS, Lansky A, Onorato IM. Behavioral surveillance among people at risk for HIV infection in the US: the National HIV Behavioral Surveillance System. Public Health Rep. 2007;122(Suppl 1):32–8.PubMedPubMedCentral
37.
go back to reference Lansky A, Abdul-Quader AS, Cribbin M, et al. Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System. Public Health Rep. 2007;122(Suppl 1):48–55.PubMedPubMedCentral Lansky A, Abdul-Quader AS, Cribbin M, et al. Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System. Public Health Rep. 2007;122(Suppl 1):48–55.PubMedPubMedCentral
38.
go back to reference Evans JL, Hahn JA, Page-Shafer K, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003;80(1):137–46.CrossRefPubMedPubMedCentral Evans JL, Hahn JA, Page-Shafer K, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003;80(1):137–46.CrossRefPubMedPubMedCentral
39.
go back to reference Coffin P, Jin H, Huriaux E, Mirzazadeh A, Raymond HF. Trends in use of health care and HIV prevention services for persons who inject drugs in San Francisco: results from National HIV Behavioral Surveillance 2005–2012. Drug Alcohol Depend. 2015;146:45–51. Coffin P, Jin H, Huriaux E, Mirzazadeh A, Raymond HF. Trends in use of health care and HIV prevention services for persons who inject drugs in San Francisco: results from National HIV Behavioral Surveillance 2005–2012. Drug Alcohol Depend. 2015;146:45–51.
Metadata
Title
Estimated Number of People Who Inject Drugs in San Francisco, 2005, 2009, and 2012
Authors
Yea-Hung Chen
Willi McFarland
Henry F. Raymond
Publication date
01-12-2016
Publisher
Springer US
Published in
AIDS and Behavior / Issue 12/2016
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-015-1268-7

Other articles of this Issue 12/2016

AIDS and Behavior 12/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.